ClinicalTrials.gg
RecruitingNCT06394440Updated Jul 8, 2024

Clinical Evaluation of Self-Adhesive Bulk-Fill Composite Versus Conventional Nano-hybrid Composite in Cervical Cavities

An interventional study of Self-Adhesive Bulkfill Composite (Surefil One) in Cervical Caries, sponsored by Misr International University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-08.

Sponsored by Misr International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The aim of this randomized clinical trial is to compare the six months clinical performance of the self-adhesive bulk-fill composite with the conventional nano-hybrid composite in the cervical lesions of teeth in the esthetic zone. In addition, to evaluate patient's satisfaction towards the self-adhesive bulk-fill material and its total operatory time.

Read the detailed description

Patient Selection Patients will be randomly recruited from Dental Clinics at Misr International University (MIU) in Cairo. Written and signed informed consents will be obtained from all patients before participating in the clinical study after being completely informed of the aims, settings, procedures, benefits, and potential side effects of the study. The form will be approved by MIU's Ethical Committee. Patients will be selected according to the inclusion and exclusion criteria, carefully diagnosed, and will be allowed to read and understand the terms and conditions of the study and subsequently sign the informed consent. A total of 54 cervical lesions will be referred to be restored in this study. Materials will be randomly assigned to each side, considering that each patient must at least include two teeth and if more, even numbers of the cervical lesions will be selected. Patients will have all their selected teeth restored on their first visit. The randomization will be performed using Microsoft Excel (Microsoft, Washington, USA) by an independent contributor. Cervical lesions will be prepared, isolated and filled with the chosen material according to randomization.

Clinical Procedures The materials that will be used to restore cervical lesions in this study are self-adhesive bulk-fill composite (Surefil One, Dentsply Sirona) and Nanohybrid composite. Materials will be used according to manufacturer's instructions. Class V cavities will be prepared, restored, finished, and polished. Each patient will at least have one tooth restored by Surefil One and one tooth at least will be restored by conventional nano-hybrid composite.

For each patient, shade selection will be performed and accordingly the suitable shade of the composite will be selected before the start of any procedure using a dental shade guide. Local anesthesia will be given at the operation site and cervical cavities on the buccal surfaces will be prepared using 330 bur and finished using a red-coded stone to finish enamel margins and to create a bevel at the incisal margin of the cavity. Rubber dam will be placed on teeth restored to isolate the operative field before the initiation of the restorative process and a stopwatch will be used to record the time taken to place both restorations; starting from their application inside the cavity and the recording will be terminated right after finishing the restorative procedures.

Intervention At least one tooth in each patient will be restored with Surefil One capsule, following manufacturer's instructions, without any prior adhesive preparations. Capsule will be placed in the automatic mixer and mixed for six to eight seconds. Cleaning of the cavity will be achieved using an air-water spray leaving a moist cavity surface. The activated capsule will be attached to the applicator gun and the material is inserted inside the cavity at the deepest portion and gradually withdrawn allowing slight overfilling. Once the restorative material is applied and excess is removed using a hand instrument, restoration will be light cured using a LED Light Curing unit. The tip of the light unit will be put in contact with the glass slide during the light-curing process. The distance between the light source and the restoration will be standardized using a standard slide to ensure fixed curing distance. Rubber dam will be removed subsequently, and the finishing process of the material will be initiated using discs and finishing stones while the restoration is moist. A single step polishing protocol is followed consequently.

Comparator In the same patient, at least one tooth will be restored by conventional nano-hybrid composite. Etching of the enamel margins by 37% phosphoric acid will be done, rinsing with water after 20 seconds afterwards, drying using air blowing, followed by active application of two layers of Prime \& Bond universal adhesive (Dentsply Sirona, Konstanz, Germany) using a micro-brush to the cavity, a waiting period of 15 seconds to allow the optimum penetration of the adhesive and curing for 20 seconds. Restorative material will be added incrementally, an increment of 2 mm thickness will be added, and light cured. Finishing of restorations will be done simultaneously after rubber dam removal using finishing discs and finishing stones. Restorations will be subsequently polished using a single step protocol of polishing.

Evaluation Procedures Cervical restorations will be inspected at baseline and after six months of restoration placement. The principal investigator will make sure to call each patient prior to their recall appointment to make sure that they show up exactly on the date and at the time of their follow up appointments. Restorations will be examined by two trained external blinded evaluators immediately after placing of restorations and their subsequent finishing and polishing without knowing which material was used in each cavity.

The USPHS criteria are selected and modified to suit the criteria chosen for the restoration evaluation. Evaluation instruments are dental mirrors, explorers, and intraoral photographs. Radiographs will only be taken if clinically indicated, for example caries diagnosis or pain experience. Adverse events regarding product safety will be recorded. Color match, surface roughness, marginal discoloration, marginal adaptation, retention, and the presence of secondary caries around restorations will be evaluated at baseline and after six months as a primary outcome. In addition, patient's satisfaction with the restoration will be measured immediately post-operative using Visual Analogue Scale (VAS) scores and the time elapsed from the start of isolation till finishing and polishing of the interventional restoration will be measured and compared to the time elapsed when restoring using a conventional composite. All observations will be recorded.

02

Conditions studied

  • Cervical Caries

Browse trials for

03

In context

Root Caries

39 studies on the registry are indexed under Root Caries; 14 are open to participants now.

This study's planned enrollment of 54 is below the median of 62 across 35 interventional studies indexed under Root Caries.

Browse Root Caries studies →

Lead sponsor

Misr International University is the lead sponsor of 46 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cervical lesions.
  • Cervical lesions of at least one mm depth; to include enamel and dentin.
  • Cervical lesions of not more than 3 mm in depth.
  • Male or female genders.
  • Medically free patients.
  • Normal occlusion.
  • Healthy Gingiva

Exclusion criteria

Exclusion Criteria:

  • Teeth showing signs of pulpitis or periapical pathosis.
  • Patients older than 60 years.
  • Patients younger than 18 years old.
  • Pregnant women.
  • Patients with history of allergy to resin.
  • Patients with disabilities.
  • Carious cervical lesions extending to proximal surfaces.
  • Carious cervical lesions on the palatal/lingual surfaces.
  • Teeth with root caries.
  • Endodontically treated teeth.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    Self-Adhesive Bulkfill Composite Restoration

    Surefil One from Dentsply will be applied to one side of teeth that contain cervical cavities.

    Combination Product: Self-Adhesive Bulkfill Composite (Surefil One)

  • Active comparator
    Nano-hybrid Composite

    Neospectra from Dentsply will be added after etching \& bonding to the other side of the teeth that contain cervical cavities.

    Combination Product: Self-Adhesive Bulkfill Composite (Surefil One)

Interventions

  • Combination productSelf-Adhesive Bulkfill Composite (Surefil One)

    It is a new self-adhesive bulkfill composite that requires no previous adhesive steps.

06

What researchers measure

Primary outcomes

  1. Clinical efficacy of the self-adhesive bulkfil composite in comparison to conventional composite

    Modified USPHS Criteria Alpha(A) Bravo(B) Charlie(C)

    Time frame: Six months

Secondary outcomes

  1. Patient's Satisfaction of the final restorations

    Visual Analogue Scale (VAS). A scale 0-10; 0 - Extremely unsatisfactory 5 - Neutral 10 - Extremely satisfactory

    Time frame: Six Months.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

Time frame: 5 Years

Access criteria: Clinicaltrials.gov

Data sharing details ↗ · clinicaltrials.gov

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Jul 2024, 16 months after the start.

Of 21 interventional studies with no phase under Root Caries, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 55. This study's planned 16 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 23, 2022
First posted
May 1, 2024
StartActual
Mar 14, 2023
Primary completionEst.
Jul 20, 2024
CompletionEst.
Jul 30, 2024
Last update
Jul 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06394440
Lead sponsor
Misr International University
Responsible party
Riham Kamal ElDessouky ElShazly (Teaching Assistant, Misr International University) — Principal investigator
First posted
May 1, 2024
Start date
Mar 14, 2023
Primary completion
Jul 20, 2024 (estimated)
Completion
Jul 30, 2024 (estimated)
Last update
Jul 8, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion